Jill May and David Dangoor CBE tell us why they’ve devoted time, effort and millions of pounds to back our vital research.
Selpercatinib will expand treatment options available for people with RET fusion positive non small cell lung cancer on the NHS in England.
How exactly do you create an exhibition looking at the hugely complex and emotive subject of cancer? You do exactly what the Science Museum has done in its superb exhibition, which I had the pleasure of attending last month.
People who survive cancer in childhood have a higher risk of ill health as they grow older, according to new research published in The Lancet Regional Health – Europe.
We speak with the industrialist, investor and Cancer Research UK supporter about his substantial donation to support our early career researchers… and why he changed his mind about cancer research.
We spoke to Dr Ishu Kataria who works with WHO to prevent the spread of infections like HPV, which causes 99% of cervical cancers worldwide.
We’ve partnered with In2science UK, an organisation that promotes diversity in STEM, to sponsor 10 young people through a mentoring programme.
Professor Eithne Costello on the challenges of ambitious trials, the evolution of early detection as a field in its own right and why a guiding framework is all important.